Back to Search Start Over

Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.

Authors :
Manegold C
Gravenor D
Woytowitz D
Mezger J
Hirsh V
Albert G
Al-Adhami M
Readett D
Krieg AM
Leichman CG
Source :
Journal of Clinical Oncology; 8/20/2008, Vol. 26 Issue 24, p3979-3986, 8p
Publication Year :
2008

Details

Language :
English
ISSN :
0732183X
Volume :
26
Issue :
24
Database :
Supplemental Index
Journal :
Journal of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
105649335